Log in
Enquire now

List of Luye Pharma patents

List of Luye Pharma patents
List of Japan Display patents
List of AVG (company) patents
List of Cerus patents
List of SBIR/STTR awards granted to ENKIDU RESEARCH, INC.
List of funding rounds for Shiprocket
Patents where
Current Assignee
Name
is
Luye PharmaLuye Pharma
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10076502 Transdermal therapeutic system for administering rivastigmine or derivatives thereof

Patent 10076502 was granted and assigned to Luye Pharma on September, 2018 by the United States Patent and Trademark Office.

Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10076502
September 18, 2018
‌
US Patent 11013697 Transdermal therapeutic system with an overtape comprising two adhesive layers

Patent 11013697 was granted and assigned to Luye Pharma on May, 2021 by the United States Patent and Trademark Office.

Luye Pharma
Luye Pharma
Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
11013697
May 25, 2021
‌
US Patent 10759076 Device for the manufacture of pharmaceutical patches

Luye Pharma
Luye Pharma
Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10759076
September 1, 2020
‌
US Patent 9616212 Implant cannula having an implant and a method for securing implants in an injection cannula

Patent 9616212 was granted and assigned to Luye Pharma on April, 2017 by the United States Patent and Trademark Office.

Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
9616212
April 11, 2017
‌
US Patent 10758495 Lattice loss reduction

Luye Pharma
Luye Pharma
Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10758495
September 1, 2020
‌
US Patent 10660863 Transdermal therapeutic system for administering an active substance

Patent 10660863 was granted and assigned to Luye Pharma on May, 2020 by the United States Patent and Trademark Office.

Luye Pharma
Luye Pharma
United States Patent and Trademark Office
United States Patent and Trademark Office
10660863
May 26, 2020
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us